Coeptis Therapeutics pursuing possible acquisition of cell therapy platform
March 29, 2023 at 14:06 PM EDT
Coeptis did not offer a timeline as to when it expects to conclude its due diligence analysis, which has since begun.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|